BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31268802)

  • 21. Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema.
    Altintas AGK; Ilhan C
    Korean J Ophthalmol; 2019 Jun; 33(3):259-266. PubMed ID: 31179657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intralenticular foreign bodies: report of eight cases and review of management.
    Arora R; Sanga L; Kumar M; Taneja M
    Indian J Ophthalmol; 2000 Jun; 48(2):119-22. PubMed ID: 11116507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Traumatic cataract and intralenticular foreign body.
    Kumar A; Kumar V; Dapling RB
    Clin Exp Ophthalmol; 2005 Dec; 33(6):660-1. PubMed ID: 16402963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Traumatic cataract.
    Ajamian PC
    Optom Clin; 1993; 3(2):49-56. PubMed ID: 8268696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined cataract extraction and intravitreal bevacizumab in eyes with choroidal neovascularization resulting from age-related macular degeneration.
    Furino C; Ferrara A; Cardascia N; Besozzi G; Alessio G; Sborgia L; Boscia F
    J Cataract Refract Surg; 2009 Sep; 35(9):1518-22. PubMed ID: 19683147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posttraumatic neovascularization.
    Natarajan R; Rao SK
    J Cataract Refract Surg; 2003 May; 29(5):861. PubMed ID: 12781259
    [No Abstract]   [Full Text] [Related]  

  • 27. Inadvertent Intra-Lenticular Injection of Anti-Vascular Endothelial Growth Factor.
    Singh SR; Kaur S; Ram J
    Ophthalmology; 2020 Sep; 127(9):1233. PubMed ID: 32828194
    [No Abstract]   [Full Text] [Related]  

  • 28. [Intravitreal bevacizumab for choroidal neovascularization associated with Best's disease].
    Velazquez-Villoria D; Macià Badia C; Rigo Quera J; Velez-Escola L; Arcos-Algaba G; Martínez-Castillo V; García-Arumí J
    Arch Soc Esp Oftalmol; 2014 Oct; 89(10):405-7. PubMed ID: 24508228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
    Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
    Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and intermediate-term outcomes of open- and closed-globe injuries in traumatic childhood cataract.
    Khokhar S; Gupta S; Yogi R; Gogia V; Agarwal T
    Eur J Ophthalmol; 2014; 24(1):124-30. PubMed ID: 23918072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic intravitreal antibiotics reduce the risk of post-traumatic endophthalmitis after repair of open globe injuries.
    Abouammoh MA; Al-Mousa A; Gogandi M; Al-Mezaine H; Osman E; Alsharidah AM; Al-Kharashi A; Abu El-Asrar AM
    Acta Ophthalmol; 2018 May; 96(3):e361-e365. PubMed ID: 28771946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection.
    Ishibashi S; Tawara A; Sohma R; Kubota T; Toh N
    Arch Ophthalmol; 2010 Dec; 128(12):1539-45. PubMed ID: 21149776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Siderosis bulbi resulting from an intralenticular foreign body.
    O'Duffy D; Salmon JF
    Am J Ophthalmol; 1999 Feb; 127(2):218-9. PubMed ID: 10030572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cataract with posterior capsule rupture following intravitreal injection.
    Shaikh N; Kumar V; Beniwal A
    Indian J Ophthalmol; 2019 Oct; 67(10):1729. PubMed ID: 31546538
    [No Abstract]   [Full Text] [Related]  

  • 35. INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS.
    Seidman CJ; Finger PT; Silverman JS; Oratz R
    Retin Cases Brief Rep; 2017 Winter; 11(1):47-50. PubMed ID: 26862924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis with Active Choroidal Neovascularization Managed with Intravitreal Bevacizumab.
    Chen SN; Chen YL; Yang BC
    Ocul Immunol Inflamm; 2020; 28(1):33-38. PubMed ID: 30994378
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
    Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
    Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal Aflibercept for Patients With Diabetic Macular Edema Refractory to Bevacizumab or Ranibizumab: Analysis of Response to Aflibercept.
    Chen YY; Chang PY; Wang JK
    Asia Pac J Ophthalmol (Phila); 2017; 6(3):250-255. PubMed ID: 28436640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal Bevacizumab for Traumatic Choroidal Rupture.
    Kim M; Kim JH; Seo Y; Koh HJ; Lee SC
    Optom Vis Sci; 2015 Oct; 92(10):e363-7. PubMed ID: 26367340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Traumatic cataract from asymptomatic nonmetallic foreign body.
    Taguri AH; Azuara-Blanco A
    J Cataract Refract Surg; 2002 Oct; 28(10):1889-90. PubMed ID: 12388052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.